Longitudinal efficacy and safety of capecitabine and cyclophosphamide as early-line treatment in patients with metastatic breast cancer: A prospective cohort study by the Kyushu Breast Cancer Study Group, Japan.

Kohjiro Mashino,Maki Tanaka,Miki Yamaguchi,Reiki Nishimura,Yutaka Yamamoto,Hiroaki Ueo,Toshihiro Tanaka,Kenichiro Koga, Tomoyuki Yoshiyama,Shoshu Mitsuyama,Kazuo Tamura, Kyushu Breast Cancer Study Group

Annals of Cancer Research and Therapy（2022）

Cited 0|Views9

No score

Abstract

Introduction: Oral combination chemotherapy using capecitabine and cyclophosphamide (XC) has demonstrated synergistic antitumor activity in preclinical studies. We investigated the efficacy and safety of early-linen XC therapy use in patients with metastatic breast cancer (MBC).

Translated text

Key words

Breast Cancer,Metastatic Breast Cancer

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined